[Skip to Content]
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
March 2010

Why the Evidence for Skin Cancer Screening Is InsufficientLessons From Prostate Cancer Screening

Author Affiliations
 

MICHAELBIGBYMDOLIVIERCHOSIDOWMD, PhDROBERT P.DELLAVALLEMD, PhD, MSPHDAIHUNGDOMDURBÀGONZÁLEZMD, PhDCATALIN M.POPESCUMD, PhDHYWELWILLIAMSMSc, PhD, FRCP

Arch Dermatol. 2010;146(3):322-324. doi:10.1001/archdermatol.2010.18

Ann Intern Med. 2009;150(3):194-198

Ann Intern Med. 2009;150(3):188-193

Question: Can screening with whole-body skin examination decrease the rate of death from melanoma?

Background: Skin cancer is the most commonly diagnosed cancer in the United States. Most skin cancers are nonmelanoma cancers, either of the basal cell or squamous cell type. The incidence of melanoma and nonmelanoma skin cancer has been increasing for the past 3 decades.

First Page Preview View Large
First page PDF preview
First page PDF preview
×